These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 17804226
1. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: Combined A- and C-ring structure-activity relationship studies. Richardson TI, Dodge JA, Wang Y, Durbin JD, Krishnan V, Norman BH. Bioorg Med Chem Lett; 2007 Oct 15; 17(20):5563-6. PubMed ID: 17804226 [Abstract] [Full Text] [Related]
2. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification. Richardson TI, Dodge JA, Durst GL, Pfeifer LA, Shah J, Wang Y, Durbin JD, Krishnan V, Norman BH. Bioorg Med Chem Lett; 2007 Sep 01; 17(17):4824-8. PubMed ID: 17614275 [Abstract] [Full Text] [Related]
3. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring. Norman BH, Richardson TI, Dodge JA, Pfeifer LA, Durst GL, Wang Y, Durbin JD, Krishnan V, Dinn SR, Liu S, Reilly JE, Ryter KT. Bioorg Med Chem Lett; 2007 Sep 15; 17(18):5082-5. PubMed ID: 17662603 [Abstract] [Full Text] [Related]
4. Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold. Richardson TI, Norman BH, Lugar CW, Jones SA, Wang Y, Durbin JD, Krishnan V, Dodge JA. Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3570-4. PubMed ID: 17485205 [Abstract] [Full Text] [Related]
5. 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists. Sun W, Cama LD, Birzin ET, Warrier S, Locco L, Mosley R, Hammond ML, Rohrer SP. Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1468-72. PubMed ID: 16412638 [Abstract] [Full Text] [Related]
7. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia. Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V. J Med Chem; 2006 Oct 19; 49(21):6155-7. PubMed ID: 17034120 [Abstract] [Full Text] [Related]
8. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. Güngör T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH. J Med Chem; 2006 Apr 20; 49(8):2440-55. PubMed ID: 16610787 [Abstract] [Full Text] [Related]
9. Structure-based design of estrogen receptor-beta selective ligands. Manas ES, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T, Hum WT, Malakian K, Wolfrom S, Bapat A, Bhat RA, Stahl ML, Somers WS, Alvarez JC. J Am Chem Soc; 2004 Nov 24; 126(46):15106-19. PubMed ID: 15548008 [Abstract] [Full Text] [Related]
10. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta. Minutolo F, Bellini R, Bertini S, Carboni I, Lapucci A, Pistolesi L, Prota G, Rapposelli S, Solati F, Tuccinardi T, Martinelli A, Stossi F, Carlson KE, Katzenellenbogen BS, Katzenellenbogen JA, Macchia M. J Med Chem; 2008 Mar 13; 51(5):1344-51. PubMed ID: 18269232 [Abstract] [Full Text] [Related]
11. Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. McDevitt RE, Malamas MS, Manas ES, Unwalla RJ, Xu ZB, Miller CP, Harris HA. Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3137-42. PubMed ID: 15876535 [Abstract] [Full Text] [Related]
13. Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands. Chesworth R, Wessel MD, Heyden L, Mangano FM, Zawistoski M, Gegnas L, Galluzzo D, Lefker B, Cameron KO, Tickner J, Lu B, Castleberry TA, Petersen DN, Brault A, Perry P, Ng O, Owen TA, Pan L, Ke HZ, Brown TA, Thompson DD, DaSilva-Jardine P. Bioorg Med Chem Lett; 2005 Dec 15; 15(24):5562-6. PubMed ID: 16219463 [Abstract] [Full Text] [Related]
14. Design of a highly selective and potent class of non-planar estrogen receptor β agonists. Sundén H, Ma JN, Hansen LK, Gustavsson AL, Burstein ES, Olsson R. ChemMedChem; 2013 Aug 15; 8(8):1283-94. PubMed ID: 23784708 [Abstract] [Full Text] [Related]
16. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity. Amari G, Armani E, Ghirardi S, Delcanale M, Civelli M, Caruso PL, Galbiati E, Lipreri M, Rivara S, Lodola A, Mor M. Bioorg Med Chem; 2004 Jul 15; 12(14):3763-82. PubMed ID: 15210143 [Abstract] [Full Text] [Related]
18. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC, Harris HA. J Med Chem; 2004 Oct 07; 47(21):5021-40. PubMed ID: 15456246 [Abstract] [Full Text] [Related]
19. Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites. De Angelis M, Stossi F, Waibel M, Katzenellenbogen BS, Katzenellenbogen JA. Bioorg Med Chem; 2005 Dec 01; 13(23):6529-42. PubMed ID: 16099659 [Abstract] [Full Text] [Related]